29
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Effect of type I interferon on experimental autoimmune uveoretinitis in rats

, , , , &
Pages 215-226 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Hiroshi Keino. (2021) Evaluation of disease activity in uveoretinitis associated with Behçet’s disease. Immunological Medicine 44:2, pages 86-97.
Read now
Xiaoli Liu, Maria Diedrichs-Möhring & Gerhild Wildner. (2019) The Role of IFN-alpha in Experimental and Clinical Uveitis. Ocular Immunology and Inflammation 27:1, pages 23-33.
Read now
Friederike Mackensen, Regina Max & Matthias D Becker. (2009) Interferons and their potential in the treatment of ocular inflammation. Clinical Ophthalmology 3, pages 559-566.
Read now
YVONNE DE KOZAK & CLAUDIE VERWAERDE. (2002) CYTOKINES IN IMMUNOTHERAPY OF EXPERIMENTAL UVEITIS. International Reviews of Immunology 21:2-3, pages 231-253.
Read now
Manfred Zierhut. (1998) Riding on a carousel with IFN-a and TNF-a. Ocular Immunology and Inflammation 6:4, pages 209-210.
Read now

Articles from other publishers (20)

Jing Lu, Yujie Wu, Yijing Yang, Jing Zhou, Bo Huang, Chengfeng Xie, Qinghua Peng & Xiaohuan Zhang. (2023) Network Pharmacology and Experimental Analyses on Astragalus membranaceus (Huangqi) Effects on Endotoxin-induced Uveitis Model in Rats . Pharmacognosy Magazine 19:3, pages 751-762.
Crossref
Durga S. Borkar & Nicholas J. Butler. 2019. Treatment of Non-infectious Uveitis. Treatment of Non-infectious Uveitis 113 129 .
John A. Gonzales & Nisha Acharya. 2019. Posterior Uveitis. Posterior Uveitis 175 207 .
N. Stübiger, K. Ruprecht & U. Pleyer. (2018) Intraokulare Entzündung bei multipler SkleroseIntraocular inflammation in multiple sclerosis. Der Ophthalmologe 115:6, pages 531-542.
Crossref
Joshua Seth EatonPaul E. MillerEllison BentleySara M. ThomasyChristopher J. Murphy. (2017) Slit Lamp-Based Ocular Scoring Systems in Toxicology and Drug Development: A Literature Survey. Journal of Ocular Pharmacology and Therapeutics 33:10, pages 707-717.
Crossref
D. Velazquez-Villoria, C. Macia-Badia, A. Segura-García, S. Pastor Idoate, G. Arcos-Algaba, L. Velez-Escola & J. García-Arumí. (2017) Efficacy of immunomodulatory therapy with interferon-β or glatiramer acetate on multiple sclerosis-associated uveitis. Archivos de la Sociedad Española de Oftalmología (English Edition) 92:6, pages 273-279.
Crossref
D. Velazquez-Villoria, C. Macia-Badia, A. Segura-García, S. Pastor Idoate, G. Arcos-Algaba, L. Velez-Escola & J. García-Arumí. (2017) Eficacia del tratamiento inmunomodulador con interferón-β o acetato de glatirámero en las uveítis asociadas a esclerosis múltiple. Archivos de la Sociedad Española de Oftalmología 92:6, pages 273-279.
Crossref
Takayo Watanabe, Hiroshi Keino, Akihiko Kudo, Yasuhiko Sato & Annabelle A Okada. (2016) MicroRNAs in retina during development of experimental autoimmune uveoretinitis in rats. British Journal of Ophthalmology 100:3, pages 425-431.
Crossref
Friederike Mackensen & Matthias D. Becker. 2016. Intraocular Inflammation. Intraocular Inflammation 851 861 .
A.L. Hildebrandt & F. Mackensen. (2014) Uveitis bei multipler SkleroseUveitis in multiple sclerosis. Der Ophthalmologe 111:8, pages 733-739.
Crossref
Arpita S. Bharadwaj, Binoy Appukuttan, Phillip A. Wilmarth, Yuzhen Pan, Andrew J. Stempel, Timothy J. Chipps, Eric E. Benedetti, David O. Zamora, Dongseok Choi, Larry L. David & Justine R. Smith. (2013) Role of the retinal vascular endothelial cell in ocular disease. Progress in Retinal and Eye Research 32, pages 102-180.
Crossref
Min Sun, Yan Yang, Peizeng Yang, Bo Lei, Liping Du & Aize Kijlstra. (2011) Regulatory Effects of IFN-β on the Development of Experimental Autoimmune Uveoretinitis in B10RIII Mice. PLoS ONE 6:5, pages e19870.
Crossref
Ch. Pagnoux & V. Mallet. 2010. Les Uvéites. Les Uvéites 661 665 .
Ch. Stathopoulos. 2010. Les Uvéites. Les Uvéites 405 413 .
Srilakshmi M. Sharma, Andrew D. Dick & Athimalaipet V. Ramanan. (2009) Non-Infectious Pediatric Uveitis. Pediatric Drugs 11:4, pages 229-241.
Crossref
J. Wenzel, S. Zahn, S. Mikus, A. Wiechert, T. Bieber & T. T?ting. (2007) The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets. British Journal of Dermatology 157:4, pages 752-757.
Crossref
Valerie Touitou, Damien Sene, Christine Fardeau, Thi-Huong-Du Boutin, Pierre Duhaut, Jean-Charles Piette, Phuc LeHoang, Patrice Cacoub & Bahram Bodaghi. (2007) Interferon-α2a and Vogt–Koyanagi–Harada disease: a double-edged sword?. International Ophthalmology 27:2-3, pages 211-215.
Crossref
CHRISTOPH M. E. DEUTER, INA KOETTER, ILHAN GUENAYDIN, NICOLE STUEBIGER & MANFRED ZIERHUT. (2006) INTERFERON ALFA-2A: A NEW TREATMENT OPTION FOR LONG LASTING REFRACTORY CYSTOID MACULAR EDEMA IN UVEITIS?. Retina 26:7, pages 786-791.
Crossref
Andrew D. Dick, John V. Forrester, Janet Liversidge & Andrew P. Cope. (2004) The role of tumour necrosis factor (TNF-α) in experimental autoimmune uveoretinitis (EAU). Progress in Retinal and Eye Research 23:6, pages 617-637.
Crossref
. 2004. Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach - Volume I: Principles and Methods of Immunotoxicology. Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach - Volume I: Principles and Methods of Immunotoxicology 205 217 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.